# Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/olaparib-combined-with-chemotherapy-for-recurrent-platinum-sensitive-ovarian/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Amit M. Oza,David Cibula,Ana Oaknin Benzaquen,Christopher Poole,Ron H.J. Mathijssen,Gabe S. Sonke,Nicoletta Colombo,Jiří Špaček,Peter Vuylsteke,Holger W. Hirte,Sven Mahner,Marie Plante,Barbara Schmalfeldt,Helen Mackay,Jacqui Rowbottom,Elizabeth Lowe,Brian Dougherty,J. Carl Barrett,Michael Friedländer |
| Citations | 551 |
| DOI | 10.1016/s1470-2045(14)71135-0 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2033816200 |
| PMID | 25481791 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Amit M. Oza](https://scholariq.org/researchers/amit-m-oza/)
- [Sven Mahner](https://scholariq.org/researchers/sven-mahner/)
- [Nicoletta Colombo](https://scholariq.org/researchers/nicoletta-colombo/)
- [Michael Friedländer](https://scholariq.org/researchers/michael-friedlander/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.